Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Johnson and Johnson
McKinsey
Boehringer Ingelheim
Dow

Last Updated: November 11, 2019

DrugPatentWatch Database Preview

Litigation Details for Cephalon Inc. v. Barr Laboratories (D. Del. 2005)

See Plans and Pricing

« Back to Dashboard

Cephalon Inc. v. Barr Laboratories (D. Del. 2005)

Docket   Start Trial Date Filed 2005-01-20
Court District Court, D. Delaware Date Terminated 2006-02-06
Cause 35:271 Patent Infringement Assigned To Joseph James Farnan Jr.
Jury Demand Defendant Referred To
Parties BARR LABORATORIES, INC.; CEPHALON INC.; UNIVERSITY OF UTAH RESEARCH FOUNDATION
Patents 3,996,934; 4,060,084; 4,588,580; 4,671,953; 4,743,450; 4,863,737; 5,248,699
Attorneys Chad Michael Shandler; Karen Elizabeth Keller; Kevin M. Baird; Richard H. Morse
Link to Docket External link to docket
Small Molecule Drugs cited in Cephalon Inc. v. Barr Laboratories
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Cephalon Inc. v. Barr Laboratories (D. Del. 2005)

Date Filed Document No. Description Snippet Link To Document
2005-03-25 19 Answering Brief in Opposition paragraph IV” certification to U\`S. Patent No~ 4,863,737 (“the ‘737 patent”), which, upon information and …product prior to expiration of the ‘737 patent because that patent is either invalid or will not be infringed…expiration of the ‘737 patent; and (2) set forth Barr’s basis for believing tiiat patent to be invalid and/…drugs, particularly in cases involving patents that are patently frivolous and for Which brand name manufacturers…Court of jurisdiction over Barr’s counterclaim for patent non»infr'ingement and invalidityn They are External link to document
2005-04-06 25 Exhibit A version of Pfizer‘s patented drug Accupril(R) will not infringe lw,lw§n_ Patent No. 4 743_450 ("the '…different United States patents; the '5i8 patent and the ‘699 patent Tlle ‘518 patent is directed towards…every patent holder tvho listed a patent, thereby eliminating the second prong of the test A patent holder…the '699 Fatent and U.S. Patent No. 4.356.5l8 (tlie " ‘518 patent"i I. Statenient of Facts… of 20 Page 2 tltis patent expires on Decetnber 30, 2005\ _The '699 patent covers setraline in a External link to document
2005-05-12 30 Notice (Other) the ‘737 patent” shall mean U.S. Patent No. 4,863,737. the ‘953 patent” shall mean U.S. Patent No. 4,671,953… of the ‘953 patent, the ‘953 patent, the prosecution of the ‘737 patent, ‘the 737 patent, or any foreign…or entity of the patent application(s) leading up to the issuance of the ‘737 patent 3. The arguments…United States Patent and Trademark Office during the examination or prosecution of the ‘737 patent, including…United States Patent and Trademark Office during the examination or prosecution of the ‘953 patent, Which relates External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Moodys
AstraZeneca
Medtronic
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.